GYRENasdaq United States
Market cap
$743.631 M
$6.67 +4.22%
Close of 7 Aug 2026
Revenue
$116.6M
#2467 by revenue
Earnings
$9.88M
#2051 by earnings
Shares outstanding
111,509,849
Latest filing cover page
P/E ratio
75.3
Cap ÷ net income
Where these numbers come from
Share counts and financials for Gyre Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.